Company profile: EMD Millipore
1.1 - Company Overview
Company description
- Provider of biopharmaceutical manufacturing solutions including cell culture media, filtration and purification systems; life science research tools and reagents for genomic analysis, protein sample preparation, antibodies, assays and small molecule research; laboratory water purification systems and consumables; microbial testing for pharma, cosmetics, food, beverages and municipal water; IVD/OEM kits, materials and reagents; and chemicals, reagents and labware.
Products and services
- Water Purification: Supplies laboratory-grade systems and consumables for laboratory water purification, ensuring high-quality water tailored to scientific applications
- Biopharmaceutical Manufacturing: Engineers industrial-scale bioprocess systems for biopharmaceutical production, encompassing cell culture media, filtration components, and purification systems
- Life Science Research: Supplies research-grade tools and reagents enabling genomic analysis, protein sample preparation, antibodies, assays, and small-molecule research across diverse laboratory applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EMD Millipore
Medfiles
HQ: Finland
Website
- Description: Provider of full-service contract research organization (CRO) services for the pharma, biotech, food, and medical device industries; first private CRO in Finland and the largest by range of services, with operations across the Nordic and Baltic countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medfiles company profile →
North Georgia Clinical Research
HQ: United States
Website
- Description: Provider of FDA-approved clinical trials evaluating new treatments and medications for various health conditions, conducted at its Woodstock, GA facility. Studies include an Alzheimer's prevention study, cardiovascular and diabetes trials, elevated lipoprotein(a) research, and a high cholesterol study testing an oral investigational drug to lower LDL-C and reduce cardiovascular risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full North Georgia Clinical Research company profile →
Continuum Clinical
HQ: United States
Website
- Description: Provider of Health Economics and Outcomes Research services and clinical trial engagement solutions, including the MERIS Total Engagement suite for participant and site support with real-time performance data; patient recruitment campaigns; Global Site Solutions; study/site support; retention solutions; and patient advocacy and diversity & inclusion services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Continuum Clinical company profile →
Lyophilization Services
HQ: United States
Website
- Description: Provider of lyophilization services to the pharmaceutical, biotechnology, and medical device industries, producing products in a timely, reliably consistent, GMP-compliant manner with a focus on quality and patient safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lyophilization Services company profile →
Reaction Biology
HQ: United States
Website
- Description: Provider of assay services and protein production for early-stage drug discovery, including biochemical, biophysical, electrophysiological and cell assays for high throughput screening (HTS); kinase and epigenetic assays; recombinant and custom protein production; 2D/3D cell-based assays; in vivo pharmacology (xenograft, immuno-oncology tumor models); and ADME & safety with in vitro safety screening, cardiac safety assessment, and in vivo PK/PD studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reaction Biology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EMD Millipore
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EMD Millipore
2.2 - Growth funds investing in similar companies to EMD Millipore
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EMD Millipore
4.2 - Public trading comparable groups for EMD Millipore
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →